Xgeva is a brand-name subcutaneous injection that’s prescribed for several types of bone problems. Xgeva is a biologic that contains the active ingredient denosumab and belongs to the RANK ligand (RANKL) inhibitors drug class.
Xgeva is approved by the Food and Drug Administration (FDA) to:
- Help prevent broken bones in adults with multiple myeloma: Multiple myeloma is a form of cancer that affects your bone marrow (the tissue in your bones).
- Help prevent broken bones in adults with bone metastasis caused by solid tumors: Bone metastasis occurs when cancer spreads to your bones. And a solid tumor is a lump of tissue that forms when cells grow too quickly. It’s solid because it doesn’t contain liquid.
- Treat giant cell tumors that can’t be completely removed by surgery or in cases where surgery would be too dangerous: Xgeva is approved for this use in adults and adolescents whose bones have finished growing. A giant cell tumor is a rare type of bone tumor that isn’t cancerous.
- Treat hypercalcemia caused by cancer in adults: Hypercalcemia occurs when there’s too much calcium in your blood. Also, you must have already tried a type of drug called a bisphosphonate, which helps prevent the loss of bone mass.
Drug details
You’ll find key information about Xgeva below.
- Drug form: subcutaneous injection
- Generic or biosimilar available? no
- Prescription required? yes
- Controlled substance? no
- Year of FDA approval: 2010
Xgeva is available only as a brand-name medication. Xgeva contains one active drug ingredient: denosumab.
Xgeva isn’t currently available in a biosimilar form.
A biosimilar is a drug that’s similar to a brand-name medication. A generic drug, on the other hand, is an exact copy of a brand-name medication. Biosimilars are based on biologic drugs, which are made from parts of living cells. Generics are based on regular drugs, which are made from chemicals. Biosimilars and generics tend to cost less than brand-name drugs.
Xgeva can cause mild or serious side effects. The following lists contain some of the key side effects that may occur while taking Xgeva. These lists do not include all possible side effects.
For more information on the possible side effects of Xgeva, talk with your doctor or pharmacist. They can give you tips on how to deal with any side effects that may be bothersome.
More common side effects
The more common side effects of Xgeva can include:
- tiredness
- weakness
- headache
- back pain
- joint pain
- diarrhea
- nausea
- hypophosphatemia (low levels of phosphate)
- cough
- shortness of breath
Some of these side effects may go away within a few days or a couple of weeks. If they’re more severe or don’t go away, talk with your doctor or pharmacist.
Serious side effects
Serious side effects from Xgeva aren’t common, but they can occur. Call your doctor right away if you have serious side effects. Call 911 if your symptoms feel life threatening or if you think you’re having a medical emergency.
Serious side effects, explained in more detail below in “Side effect details,” include:
- shortness of breath
- pneumonia
- osteonecrosis (bone disease caused by decreased blood flow) in your jaw
- hypercalcemia (high calcium levels) after stopping treatment with Xgeva
- hypocalcemia (low levels of calcium)
- breaks in your femur, the bone between your hip and your knee
- breaks in your spine after stopping treatment with Xgeva
- severe allergic reactions
Side effect details
You may wonder how often certain side effects occur with this drug. Here’s some detail on several of the side effects this drug may cause.
Allergic reaction
As with most drugs, some people can have an allergic reaction after taking Xgeva, but this is rare. It’s not known how often people using Xgeva have allergic reactions. Symptoms of a mild allergic reaction can include:
- skin rash
- itchiness
- flushing
A more severe allergic reaction is also rare. Symptoms of a severe allergic reaction can include:
- swelling under your skin, typically in your eyelids, lips, hands, or feet
- swelling of your tongue, mouth, or throat
- difficulty breathing or talking
- low blood pressure
Call your doctor right away if you have a severe allergic reaction to Xgeva. Call 911 if your symptoms feel life threatening or if you think you’re having a medical emergency.
Jaw and dental side effects
Problems with your mouth, teeth, and jaw while taking Xgeva could be early warning signs of osteonecrosis in your jaw. (Osteonecrosis is a condition caused by decreased blood flow to the jaw bone that can lead to death of the bone.)
Symptoms of osteonecrosis can include:
- mouth or jaw pain that lasts
- slow healing after dental surgery
- tooth infection
- toothache
- bone loss
- bone infections
- gums that have sores or recede (pull away from teeth)
In addition to taking Xgeva, other factors may increase your risk of developing osteonecrosis of the jaw during your treatment:
- not brushing, flossing, or seeing your dentist on a regular basis
- wearing dentures that don’t fit well
- having tooth problems, such as severe tooth decay, tooth infection, or a broken tooth
- having had a serious dental procedure, such as a tooth extraction, a dental implant, or oral surgery
- having an infection
- having certain conditions, such as diabetes or anemia (low level of red blood cells)
If you notice any symptoms of osteonecrosis while taking Xgeva, tell your doctor right away. They may test the bone density in your jaw to see if you have bone loss. If you do, they may recommend a drug other than Xgeva.
In clinical studies, the longer people took Xgeva, the higher their risk for osteonecrosis. The most common reason people stopped taking Xgeva during the studies was osteonecrosis of the jaw.
For information on how often jaw and dental effects occurred in Xgeva clinical studies, see the “Adverse Reactions” section of the Xgeva prescribing information.
Bone, joint, or muscle pain
Xgeva can cause pain in your bones, joints, or muscles. This pain can be severe or may greatly decrease your quality of life.
This pain can occur right after you start treatment with Xgeva or months later. The pain usually develops within the first year of taking Xgeva, if it occurs at all. It’s not known how often people using Xgeva have bone, joint, or muscle pain.
If you have pain in your bones, joints, or muscles while taking Xgeva, tell your doctor. They may pause your Xgeva treatment or suggest a change in medication.
Hypercalcemia
High levels of calcium, called hypercalcemia, can occur after treatment with Xgeva. In clinical studies, hypercalcemia was reported in people with growing skeletons and those with giant cell tumors within 1 year after they stopped taking Xgeva. (Xgeva is not approved for use in children whose skeletons are still growing.)
Symptoms of hypercalcemia can include:
- headache
- fatigue
- extreme thirst
- urinating much more often than usual
- back pain
- nausea
- abdominal pain
- feeling less hungry than usual
- constipation
- vomiting
If you notice symptoms of hypercalcemia while taking Xgeva or after you stop taking the drug, tell your doctor. They may pause your Xgeva use to treat the hypercalcemia or recommend a drug other than Xgeva.
Hypocalcemia
Taking Xgeva can lead you to have hypocalcemia (low levels of calcium). And if you have hypocalcemia before you start taking Xgeva, the drug can lower your calcium levels even further.
Before you start taking Xgeva, it’s important that your doctor checks your calcium level. If it’s too low, they may prescribe calcium and vitamin D supplements to help raise your calcium level.
Symptoms of hypocalcemia can include:
- confusion or memory loss
- hallucinations (seeing or hearing things that aren’t really there)
- depression
- muscle spasms (twitches)
- muscle cramps
- numbness and tingling in your hands, feet, or face
- weak and brittle nails
- bones that break easily
Bone fractures
If you notice symptoms of hypocalcemia while taking Xgeva, tell your doctor. They may test you for low calcium levels. Depending on the results, your doctor may recommend a drug other than Xgeva.
For information on how often hypocalcemia occurred in Xgeva clinical studies, see the “Adverse Reactions” section of the Xgeva prescribing information.
Bone fracture (broken bone) can be a side effect during and after Xgeva treatment. This can occur in bones such as your femur or in your spine. Symptoms of a fracture in your femur include unusual pain in your thigh, hip, or groin. Symptoms of a fracture in your spine include back or neck pain.
Weeks to months before people had a complete fracture in their femur, they reported feeling dull, aching pain in their thigh. And before people had a fracture in their spine, they reported head, neck, or back pain.
If you notice symptoms of a bone fracture while taking Xgeva, tell your doctor right away. Your doctor may recommend a drug other than Xgeva.
For information on how often bone fractures occurred in Xgeva clinical studies, see the “Clinical Trials” section of the Xgeva prescribing information.
Side effects in children
Xgeva is approved to treat giant cell tumors in adolescents whose bones have finished growing. Side effects of the drug in adolescents are expected to be the same as side effects of Prolia in adults. To learn more, please see the “Xgeva side effects” section above.
As with all medications, the cost of Xgeva can vary.
The actual price you’ll pay depends on your insurance plan and your location.
Financial and insurance assistance
If you need financial support to pay for Xgeva, or if you need help understanding your insurance coverage, assistance is available.
Amgen Inc., the manufacturer of Xgeva, offers a program called Amgen SupportPlus for people who have health insurance coverage. For more information about this program, and to find out if you’re eligible for support, call 866-264-2778 or visit the program website.
For people without health insurance, a program called Amgen Safety Net Foundation is available to help with treatment costs. For more information about this program, and to find out if you’re eligible for support, call 888-762-6436 or visit the program website.
The Xgeva dosage your doctor prescribes will depend on several factors. These include:
- the type and severity of the condition you’re using Xgeva to treat
- your age
- other medical conditions you may have
The following information describes dosages that are commonly used or recommended. However, be sure to take the dosage your doctor prescribes for you. Your doctor will determine the best dosage to suit your needs.
Drug forms and strengths
Xgeva comes as a solution in a single-dose vial. Each vial contains 120 milligrams per 1.7 milliliters (mg/mL) of solution.
Dosage for multiple myeloma
The recommended dose of Xgeva for multiple myeloma is 120 mg once every 4 weeks.
A healthcare professional will give you Xgeva as a subcutaneous injection. Possible injection spots are your upper arm, upper thigh, or abdomen. You’ll go to a clinic or your doctor’s office for an injection once every 4 weeks.
Your doctor may also prescribe calcium and vitamin D supplements to help prevent or treat low calcium levels.
Dosage for bone metastasis from solid tumors
The recommended dose of Xgeva for bone metastasis from solid tumors is 120 mg once every 4 weeks.
A healthcare professional will give you Xgeva as a subcutaneous injection. Possible injection spots are your upper arm, upper thigh, or abdomen. You’ll go to a clinic or your doctor’s office for an injection once every 4 weeks.
Your doctor may also prescribe calcium and vitamin D supplements to help prevent or treat low calcium levels.
Dosage for giant cell tumors
The recommended dose of Xgeva for certain giant cell tumors is 120 mg once every 4 weeks.
A healthcare professional will give you Xgeva as a subcutaneous injection. Possible injection spots are your upper arm, upper thigh, or abdomen. You’ll go to a clinic or your doctor’s office for an injection once every 4 weeks.
During your first month of treatment, you’ll need extra injections of 120 mg on days 8 and 15.
Your doctor may also prescribe calcium and vitamin D supplements to help prevent or treat low calcium levels.
Dosage for hypercalcemia caused by cancer
The recommended dose of Xgeva for hypercalcemia caused by cancer is 120 mg once every 4 weeks.
A healthcare professional will give you Xgeva as a subcutaneous injection. Possible injection spots are your upper arm, upper thigh, or abdomen. You’ll go to a clinic or your doctor’s office for an injection once every 4 weeks.
During your first month of treatment, you’ll need extra injections of 120 mg on days 8 and 15.
Pediatric dosage
Xgeva is approved to treat giant cell tumors in adolescents whose bones have finished growing. The recommended dose for these adolescents is 120 mg once every 4 weeks.
A healthcare professional will give your adolescent Xgeva as a subcutaneous injection. Possible injection spots are their upper arm, upper thigh, or abdomen. They’ll need to go to a clinic or their doctor’s office for an injection once every 4 weeks.
During their first month of treatment, your adolescent will need extra injections of 120 mg on days 8 and 15.
What do I do if I miss a dose?
If you miss an appointment to receive a dose of Xgeva, call your doctor. The office staff can make a new appointment and adjust the timing of future visits, if needed.
To help you remember your appointments, write your Xgeva treatment schedule in a calendar. You can also set a reminder on your phone.
Will I need to use this drug long term?
Xgeva is meant to be used as a long-term treatment. If you and your doctor determine that Xgeva is safe and effective for you, you’ll likely take it long term.
Other drugs are available that can treat your condition. Some may be better suited for you than others. If you’re interested in finding an alternative to Xgeva, talk with your doctor. They can tell you about other medications that may work well for you.
Note: Some of the drugs listed here are used off-label to treat these specific conditions. Off-label use is when a drug that’s approved to treat one condition is used to treat a different condition.
Alternatives for multiple myeloma
Examples of other drugs that may be used to treat multiple myeloma include:
- Alkylating agents, such as:
- melphalan (Alkeran, Evomela)
- cyclophosphamide
- Bisphosphonates, such as:
- pamidronate disodium (Aredia)
- zoledronic acid (Zometa)
- Bone resorption inhibitors, such as:
- pamidronate disodium (Aredia)
- Cytolytic antibodies such as:
- daratumumab (Darzalex)
- Cytotoxic antibiotics, such as:
- doxorubicin hydrochloride liposome (Doxil)
- Hematopoietic stem cell mobilizers, such as:
- plerixafor (Mozobil)
- Histone deacetylase inhibitors, such as:
- panobinostat (Farydak)
- Immunomodulatory agents, such as:
- Immunostimulatory antibodies, such as:
- elotuzumab (Empliciti)
- Nitrosoureas, such as:
- carmustine (BiCNU)
- Proteasome inhibitors, such as:
Alternatives for bone metastasis from solid tumors
Examples of other drugs that may be used to treat bone metastasis from solid tumors include:
- Bisphosphonates, such as:
- Radiopharmaceuticals, such as:
- strontium-89 (Metastron)
- samarium-153 (Quadramet)
- radium-223 (Xofigo)
Alternatives for giant cell tumors
Chemotherapy drugs are an example of another type of drug that may be used to treat giant cell tumors.
Alternatives for hypercalcemia caused by cancer
Examples of other drugs that may be used to treat hypercalcemia caused by cancer include:
- Bisphosphonates, such as:
- pamidronate (Aredia)
- zoledronic acid (Zometa)
- Hormones, such as:
- calcitonin (Miacalcin)
- Glucocorticoids, such as:
- hydrocortisone (Cortef)
- prednisone (Deltasone)
- Calcimimetics, such as:
- cinacalcet (Sensipar)
You may wonder how Xgeva compares to other medications that are prescribed for similar uses. Here we look at how Xgeva and Zometa are alike and different.
Uses
The Food and Drug Administration (FDA) has approved Xgeva and Zometa to treat certain conditions that affect your skeleton and involve bone tumors.
Multiple myeloma
Xgeva is approved to help prevent broken bones in adults with multiple myeloma. This is a form of cancer that affects your bone marrow (the tissue in your bones).
Zometa is approved to treat bone metastases in multiple myeloma when used with a type of anticancer drug called an antineoplastic. (Bone metastases are cancer cells that have moved from another part of the body into the bones.) Zometa is prescribed for this use in adults.
Bone metastasis from solid tumors
Xgeva is approved to help prevent broken bones in adults with bone metastasis from solid tumors. Bone metastasis occurs when cancer spreads to your bones. And a solid tumor is a lump of tissue that forms when cells grow too quickly. It’s solid because it doesn’t contain liquid.
Zometa is approved to treat bone metastasis from solid tumors when used with a type of anticancer drug called an antineoplastic. In some cases, Zometa may be used to treat prostate cancer. However, the cancer must have gotten worse after you tried at least one type of hormone therapy. Zometa is prescribed for this use in adults.
Giant cell tumors
Xgeva is approved to treat giant cell tumors that can’t be completely removed by surgery or in cases where surgery would be too dangerous. A giant cell tumor is a rare type of bone tumor that isn’t cancerous. Xgeva is prescribed for this use in adults and adolescents whose bones have finished growing.
Zometa isn’t approved to treat giant cell tumors.
Hypercalcemia caused by cancer
Both Xgeva and Zometa are approved to treat hypercalcemia caused by cancer in adults. Hypercalcemia occurs when there’s too much calcium in your blood.
To use Xgeva, you must have already tried a type of drug called a bisphosphonate, which helps prevent the loss of bone mass. Zometa is a bisphosphonate.
Drug forms and administration
Xgeva contains the drug denosumab. Zometa contains the drug zoledronic acid.
For Xgeva
A healthcare professional will give you Xgeva as a subcutaneous injection. You’ll go to a clinic or your doctor’s office for your injections. The drug comes as a solution in a single-dose vial. Each vial contains 120 milligrams per 1.7 milliliters (mg/mL) of solution.
Xgeva is given once every 4 weeks. For giant cell tumors and hypercalcemia caused by cancer, you’ll need extra doses on days 8 and 15.
For Zometa
Zometa is given as an intravenous (IV) infusion in a clinic or your doctor’s office. This is an injection into your vein that’s given over a period of time. This infusion should last at least 15 minutes. The drug comes as a liquid that’s available in two forms:
- a single-use bottle that contains 4 mg/100 mL of the drug
- a single-use vial that contains 4 mg/5 mL of the drug
For hypercalcemia related to cancer, Zometa is given as a single dose of 4 mg. If needed, a second dose can be given after at least 7 days.
For multiple myeloma and bone metastasis from solid tumors, Zometa is given at a dose of 4 mg every 3 to 4 weeks.
Side effects and risks
Xgeva and Zometa are both approved to treat some of the same conditions. Therefore, both medications can cause very similar and very different side effects. Below are examples of these side effects.
More common side effects
These lists contain examples of more common side effects that can occur with Xgeva, with Zometa, or with both drugs (when taken individually).
- Can occur with Xgeva:
- Can occur with Zometa:
- body aches
- fever that’s usually mild and lasts a short time
- anemia (low level of red blood cells)
- vomiting
- constipation
- flu-like symptoms, including chills and feeling unwell
- Can occur with Xgeva and Zometa
- tiredness
- nausea
- mild allergic reactions
Serious side effects
These lists contain examples of serious side effects that can occur with Xgeva, with Zometa, or with both drugs (when taken individually).
- Can occur with Xgeva:
- osteonecrosis (bone disease caused by decreased blood flow) in your jaw
- hypocalcemia, also known as low calcium levels
- breaks in your femur, the bone between your hip and knee
- multiple breaks in the bones in your spine after stopping treatment with Xgeva
- hypercalcemia, also known as high calcium levels, after stopping treatment with Xgeva
- Can occur with Zometa:
- new or unusual pain in your hips, thighs, groin, jaw, or ears
- eye problems, such as redness, itching, swelling, or sensitivity to light
- irregular heartbeat
- sores in your jaw or mouth
- kidney problems, such as urinating more or less often than usual
- seizures
- severe dizziness
- difficulty breathing
- Can occur with both Xgeva and Zometa:
- severe allergic reactions
- increased or severe pain in your bones, joints, or muscles
Effectiveness
Studies have found that both Xgeva and Zometa are effective in treating their approved uses.
Costs
Xgeva and Zometa are both brand-name drugs. Neither drug is available in biosimilar form.
A biosimilar is a drug that’s similar to a brand-name medication. A generic drug, on the other hand, is an exact copy of a brand-name medication. Biosimilars are based on biologic drugs, which are made from parts of living cells. Generics are based on regular drugs, which are made from chemicals. Biosimilars and generics tend to cost less than brand-name drugs.
The actual price you’ll pay for either drug depends on your insurance plan and your location.
You may wonder how Xgeva compares to other medications that contain the same active ingredient, denosumab. Here we look at how Xgeva and Prolia are alike and different.
Uses
The Food and Drug Administration (FDA) has approved Xgeva and Prolia to treat certain bone conditions.
Xgeva is FDA-approved to:
- Help prevent broken bones in adults with multiple myeloma: Multiple myeloma is a form of cancer that affects your bone marrow (the tissue in your bones).
- Help prevent broken bones in adults with bone metastasis caused by solid tumors: Bone metastasis occurs when cancer spreads to your bones. And a solid tumor is a lump of tissue that forms when cells grow too quickly. It’s solid because it doesn’t contain liquid.
- Treat giant cell tumors that can’t be completely removed by surgery or in cases where surgery would be too dangerous: Xgeva is approved for this use in adults and adolescents whose bones have finished growing. A giant cell tumor is a rare type of bone tumor that isn’t cancerous.
- Treat hypercalcemia caused by cancer in adults: Hypercalcemia occurs when there’s too much calcium in your blood. Also, you must have already tried a type of drug called a bisphosphonate, which helps prevent the loss of bone mass.
Prolia is FDA-approved to treat adults who have a high risk of breaking their bones, including:
- females* who have gone through menopause and have osteoporosis
- males* with osteoporosis
- males and females with glucocorticoid-induced osteoporosis
- males who are receiving androgen deprivation therapy for nonmetastatic prostate cancer
- females who are receiving adjuvant aromatase inhibitor therapy for breast cancer
* Sex and gender exist on spectrums. Use of the terms “male” and “female” in this article refers to sex assigned at birth.
Drug forms and administration
Both Xgeva and Prolia are given by your healthcare professional as a subcutaneous injection.
Xgeva comes as a solution in a single-dose vial. Each vial contains 120 milligrams per 1.7 milliliters (mg/mL) of solution. Prolia comes in a single-dose prefilled syringe with 60 mg/mL of solution.
Xgeva is given once every 4 weeks. For giant cell tumors and hypercalcemia caused by cancer, you’ll need extra doses on days 8 and 15. Prolia injections are given every 6 months.
Side effects and risks
Xgeva and Prolia both contain the drug denosumab. Therefore, both medications can cause very similar side effects. Below are examples of these side effects.
More common side effects
This list contains examples of more common side effects that can occur with both Xgeva and Prolia:
Serious side effects
This list contains examples of serious side effects that can occur with Xgeva and Prolia:
- severe allergic reactions
- osteonecrosis (bone disease caused by decreased blood flow) in your jaw
- hypocalcemia, also known as low calcium levels*
- breaks in your femur, the bone between your hip and knee
- multiple breaks in the bones in your spine after stopping treatment with Xgeva
- hypercalcemia, also known as high calcium levels, after stopping treatment with Xgeva
* Prolia has a boxed warning for the risk of severe hypocalcemia in people with advanced chronic kidney disease. A boxed warning is the most serious warning from the FDA. It alerts doctors and patients about drug effects that may be dangerous. To learn more, see Prolia’s prescribing information.
Effectiveness
Xgeva and Prolia are similar in that they have the same active ingredient, denosumab. However, each has different FDA-approved uses.
These drugs haven’t been compared to each other in clinical studies. However, studies have found that both Xgeva and Prolia are effective in treating their approved uses.
Costs
Xgeva and Prolia are both brand-name drugs. Neither drug is available in biosimilar form.
A biosimilar is a drug that’s similar to a brand-name medication. A generic drug, on the other hand, is an exact copy of a brand-name medication. Biosimilars are based on biologic drugs, which are made from parts of living cells. Generics are based on regular drugs, which are made from chemicals. Biosimilars and generics tend to cost less than brand-name drugs.
The actual price you’ll pay for either drug depends on your insurance plan and your location.
The Food and Drug Administration (FDA) approves prescription drugs such as Xgeva to treat certain conditions. Xgeva may also be used off-label for other conditions. Off-label use is when a drug that’s approved to treat one condition is used to treat a different condition.
Xgeva for prostate cancer complications
Prostate cancer usually affects males* older than age 50 years. Your risk of developing prostate cancer increases as you get older.
Sometimes, prostate cancer can spread from the prostate to other parts of the body. The disease usually spreads to bones first. Xgeva may help prevent or delay serious complications from prostate cancer spreading to bones.
* Sex and gender exist on spectrums. Use of the terms “male” and “female” in this article refers to sex assigned at birth.
Xgeva for multiple myeloma
Multiple myeloma is a form of cancer that affects your bone marrow (the tissue in your bones). The disease changes plasma cells, which are a kind of white blood cell that helps fight infections.
These changed cells crowd out healthy cells. When your body doesn’t make enough healthy bone cells, your bones may become weak and break. Xgeva is used to help prevent broken bones in people with multiple myeloma.
Xgeva for breast cancer complications
Breast cancer affects cells in the breast and causes them to divide and multiply. When breast cancer spreads to other body parts, it’s called metastatic breast cancer. In some cases, the cancer can reach your bones.
Xgeva is used to help prevent or delay bone problems in people with breast cancer that’s spread to their bones. The drug is also used to treat other complications of cancer, such as hypercalcemia of malignancy (high levels of calcium).
Xgeva for bone metastasis
Xgeva is approved to help prevent broken bones in people with bone metastasis from solid tumors. Bone metastasis occurs when cancer spreads to your bones. And a solid tumor is a lump of tissue that forms when cells grow too quickly. It’s solid because it doesn’t contain liquid.
Xgeva for hypercalcemia
When cancer moves from a part of your body to your bones, the cancer cells can crowd out healthy bone cells. These bone cells release calcium, which moves into your bloodstream. Too much calcium in your blood is called hypercalcemia.
Xgeva is approved to treat hypercalcemia of malignancy. This is hypercalcemia that’s related to cancer. You must have already tried a type of drug called a bisphosphonate, which helps prevent the loss of bone mass.
Some types of cancer have higher rates of hypercalcemia, including:
- breast cancer
- lung cancer
- multiple myeloma
Xgeva and children
In some cases, Xgeva is approved to treat certain tumors in adolescents whose bones have finished growing. Xgeva is used to treat giant cell tumors that can’t be completely removed by surgery or in cases where surgery would be too dangerous. A giant cell tumor is a rare type of bone tumor that isn’t cancerous.
In studies, adolescents who took Xgeva while their bones were still growing developed hypercalcemia after they stopped treatment. (Hypercalcemia refers to high levels of calcium in your blood.) Adolescents also developed hypercalcemia if they took Xgeva for off-label uses.
Alcohol hasn’t been shown to interact with Xgeva.
If you drink alcohol, ask your doctor how much is safe for you to consume while you take Xgeva.
Xgeva can interact with several other medications. It can also interact with certain supplements as well as certain foods.
Different interactions can cause different effects. For instance, some interactions can interfere with how well a drug works. Other interactions can increase the number of side effects or make them more severe.
Xgeva and other medications
Below is a list of medications that can interact with Xgeva. This list does not contain all drugs that may interact with Xgeva.
Before taking Xgeva, talk with your doctor and pharmacist. Tell them about all prescription, over-the-counter, and other drugs you take. Also tell them about any vitamins, herbs, and supplements you use. Sharing this information can help you avoid potential interactions.
If you have questions about drug interactions that may affect you, ask your doctor or pharmacist.
Xgeva and immunosuppressants
Taking Xgeva and immunosuppressants together can weaken your immune system (your body’s defense against disease). This can increase your risk for serious infections, especially if your immune system is already weak.
Examples of immunosuppressant drugs that may increase your risk for serious infections include:
- Corticosteroids, such as:
- prednisone (Deltasone, Orasone)
- budesonide (Entocort EC)
- prednisolone (Millipred)
- Biologics, such as:
- Monoclonal antibodies, such as:
- basiliximab (Simulect)
- daclizumab (Zinbryta)
If your immune system is weak or if you’re taking an immunosuppressant, talk with your doctor before using Xgeva. They may recommend different medications for you.
Xgeva and etelcalcetide
Taking Xgeva and etelcalcetide can decrease the level of calcium in your blood. This can lead to hypocalcemia (low level of calcium).
For symptoms of hypocalcemia, see the “Side effect details” section above. If you have any symptoms of hypocalcemia while taking Xgeva, call your doctor right away.
Xgeva and siponimod
Taking Xgeva and siponimod together can weaken your immune system (your body’s defense against disease). This can increase your risk for serious infections.
If you’re taking siponimod, talk with your doctor before using Xgeva. They may choose a different medication that does not interact with siponimod.
Xgeva and Prolia
Xgeva and Prolia both contain the same active ingredient, denosumab. So if you use Xgeva and Prolia, you’d be taking more than the amount of denosumab that’s safe for you. This may cause an increased risk of side effects and more severe side effects such as hypercalcemia.
If you’re taking Prolia, talk with your doctor before using Xgeva. They may have you use one or the other drug, but not both.
Xgeva and Faslodex (not an interaction)
Xgeva and fulvestrant (Faslodex) don’t interact with one another. The two drugs are often used together to help treat some forms of breast cancer.
You should take Xgeva according to your doctor or healthcare professional’s instructions.
A healthcare professional will give you Xgeva as a subcutaneous injection. Possible injection spots are your upper arm, upper thigh, or abdomen. You’ll go to a clinic or your doctor’s office for your injections.
When to take
You’ll have an injection of Xgeva once every 4 weeks. For giant cell tumors and hypercalcemia caused by cancer, you’ll need extra doses on days 8 and 15.
To help you remember your appointments, write your Xgeva treatment schedule in a calendar. You can also set a reminder on your phone.
Although the tissue in your bones is constantly breaking down, your body builds the tissue back up, which helps keep your bones strong.
When you have cancer that started in or spread to your bones, this breakdown/buildup process can be out of balance. A protein called RANK ligand (RANKL) usually helps keep the process of breaking down bone and rebuilding bone in balance. But when cancer cells invade bones, RANKL can become too active. This can cause the cancer cells to increase the breakdown of the bone, leaving bones weak and more likely to break.
Xgeva binds to RANKL and prevents RANKL from attaching to its receptor. Receptors are proteins on the outside of cells that act like docking stations. By blocking RANKL from binding to its receptor, Xgeva helps decrease the level of bone breakdown. This is the way Xgeva works in helping prevent bone fractures and breaks in multiple myeloma and bone metastasis. (Bone metastasis occurs when cancer spreads to your bones.)
Xgeva also works to treat giant cell tumors, which are a rare type of bone tumor that isn’t cancerous. Giant cell tumors have a high level of RANKL in their cells. Xgeva binds to RANKL in the tumor cells and helps prevent the tumors from growing. The drug can also shrink the tumors.
In addition, Xgeva helps treat hypercalcemia caused by cancer. Hypercalcemia occurs when there’s too much calcium in your blood. When bone is broken down and reabsorbed into the body, calcium levels rise. Xgeva binds to the RANKL protein, preventing RANKL from attaching to its receptor. This prevents bone breakdown, which in turn decreases the amount of calcium that’s released into the bloodstream. The end result is reduced calcium levels.
How long does it take to work?
In clinical studies, within 1 week of starting treatment, most people who took Xgeva had a meaningful reduction in bone turnover markers in their blood. (This is a sign that the drug is strengthening your bones). Each person’s response to Xgeva will be unique, though.
Xgeva hasn’t been tested in pregnant people. In animal studies, Xgeva harmed the offspring when the drug was given to the pregnant mother. Xgeva also harmed the offspring when the mother was given the drug within the 5 months before they became pregnant. However, animal studies don’t always predict what will happen in humans.
If you’re pregnant or are planning to become pregnant, you shouldn’t take Xgeva. Talk with your doctor about other treatment options.
Results from animal studies show that Xgeva isn’t safe to take during pregnancy. Because of possible risks to infants, females* should use birth control (contraception) while they’re taking Xgeva. Females should also use birth control for at least 5 months after they stop taking Xgeva.
If you’re taking Xgeva and have any questions about birth control, talk with your doctor.
* Sex and gender exist on spectrums. Use of the terms “male” and “female” in this article refers to sex assigned at birth.
There’s no information about Xgeva in human breast milk. In animal studies, Xgeva was found in breast milk. However, studies in animals don’t always reflect what will happen in humans.
If you’re taking Xgeva and are thinking about breastfeeding your child, talk with your doctor. They can help you find the best way to feed your child.
Here are answers to some frequently asked questions about Xgeva.
Is Xgeva chemotherapy?
No, Xgeva isn’t chemotherapy. Xgeva is a targeted therapy. This type of treatment targets cancer cells and tends to leave healthy cells alone.
Chemotherapy is a drug treatment that uses powerful chemicals to kill fast-growing cells in your body. It’s most often used to treat cancer because cancer cells grow and multiply quickly. Chemotherapy drugs act on all cells in your body that are growing rapidly, not just cancer cells.
Is Xgeva the same as Prolia?
No, Xgeva and Prolia are different brand-name prescription drugs, but they share some similarities. The Food and Drug Administration (FDA) has approved the drugs Xgeva and Prolia to treat certain bone conditions. And both drugs contain the active ingredient denosumab. Drugs with the same active ingredient can be used for different things based on how much and how often you take them.
Because Xgeva and Prolia both contain denosumab, you shouldn’t take these medications together. If you did, you’d be taking more than the amount of denosumab that’s safe for you. And this could increase your risk for side effects such as osteonecrosis (bone disease caused by decreased blood flow) and hypocalcemia (low levels of calcium). See the “Xgeva side effects” section above for more information.
To learn more about how these two drugs compare, see the “Xgeva vs. Prolia” section above. And if you have questions about Xgeva or Prolia, talk with your doctor or pharmacist.
Do I need to take calcium supplements with Xgeva?
You might. Taking Xgeva can lead you to have hypocalcemia (low levels of calcium). And if you have hypocalcemia before you start taking Xgeva, the drug can lower your calcium levels even further.
To help prevent or treat low calcium levels, your doctor may prescribe calcium supplements if you’re taking Xgeva for:
- multiple myeloma
- bone metastasis from solid tumors
- certain giant cell tumors
Along with the calcium supplements, your doctor may also prescribe vitamin D supplements. Vitamin D helps your bones absorb calcium.
While you’re taking Xgeva, it’s a good idea to know the symptoms of hypocalcemia. See the “Serious side effects” section above for a list of symptoms. Tell your doctor if you notice any of them while taking the drug.
And if you have questions about hypocalcemia during your Xgeva treatment, talk with your doctor.
Can I use either Xgeva or Prolia to treat osteoporosis?
Of the two drugs, only Prolia is approved to treat osteoporosis in certain cases. Prolia is used for people who have a high risk of breaking their bones, including:
- females* who have gone through menopause and have osteoporosis
- males* with osteoporosis
- males and females with glucocorticoid-induced osteoporosis
Although Xgeva is used to treat certain bone conditions, the drug isn’t approved to treat osteoporosis.
For more about these two drugs, see the “Xgeva vs. Prolia” section above. And if you have questions about Xgeva, Prolia, or how to treat osteoporosis, talk with your doctor.
* Sex and gender exist on spectrums. Use of the terms “male” and “female” in this article refers to sex assigned at birth.
How can I prevent jaw bone problems?
To help prevent jaw problems, it’s important to keep your mouth healthy. You can help do this by brushing and flossing every day, as well as seeing your dentist on a regular basis.
Problems with your mouth, teeth, and jaw while taking Xgeva are often early warning signs of osteonecrosis in your jaw. This is a condition in which the cells in your jaw die. (For more about osteonecrosis, see the “Side effect details” section above.)
Keep in mind that certain dental procedures can put you at risk for problems such as slow healing or infection in your jaw. These procedures include tooth extraction, root canal, and dental implant surgery. If you need minor dental surgery during Xgeva treatment, watch for any symptoms you have afterward. Tell your dentist if you have any pain or wounds in your mouth or jaw that are slow to heal.
If you have questions about mouth and jaw problems while taking Xgeva, ask your dentist or doctor.
Before taking Xgeva, talk with your doctor about your health history. Xgeva may not be right for you if you have certain medical conditions or other factors affecting your health. These include:
- Hypocalcemia: If you have hypocalcemia (low levels of calcium), your doctor will need to treat the condition before you start taking Xgeva. Your doctor may prescribe calcium and vitamin D supplements to help raise your calcium level.
- Allergic reactions: If you’ve had an allergic reaction to Xgeva or any of its ingredients, you shouldn’t take the drug. Talk with your doctor about other treatments that are a better choice for you.
- Pregnancy: If you’re pregnant or are planning to become pregnant, you shouldn’t take Xgeva. For more information, please see the “Xgeva and pregnancy” section above.
- Breastfeeding: If you’re taking Xgeva and are thinking about breastfeeding your child, talk with your doctor. For more information, please see the “Xgeva and breastfeeding” section above.
Note: For more information about the potential negative effects of Xgeva, see the “Xgeva side effects” section above.
Disclaimer: Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.